Acting under the radar in the US, the Israeli company is revolutionizing orthopedic medicine and bone healing by introducing innovative fiber materials.
American-Iranian investor Amir Heshmatpour made his fortune in US biotech companies. He’s now in Israel with NeOnc, developer of a nasally administered brain cancer drug.